The FDA has accepted for review the resubmitted BLA for prademagene zamikeracel for recessive dystrophic epidermolysis bullosa.

The United States contributed to the Epidermolysis Bullo's highest prevalent cases, accounting for ~65% of the 7MM in 2023.

Carol Schober-Flores, BSN, RN, is a Mohs Surgical Nurse and Epidermolysis Bullosa Nurse Specialist, University Hospital, Denver, CO. Topical ointments can be applied directly over the Mepitel ...

The football star is the vice president of Debra UK which raises awareness of epidermolysis bullosa, a group of genetic skin ...

Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa ...

Irish actor Colin Farrell recently finished the Dublin Marathon in 4:06:45, and he ran the last 2.5 miles while pushing his ...

However, in recent years he has worked as vice president of Debra UK, helping to raise awareness of epidermolysis bullosa (EB ...

FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025Company ...

Award-winning actor and runner Colin Farrell finished the Dublin Marathon in 4:06:45 while pushing his friend in wheelchair ...

Relief Therapeutics announces positive final results of RLF-TD011 trial in epidermolysis bullosa: Geneva Tuesday, November 12, 2024, 10:00 Hrs [IST] Relief Therapeutics Holding SA ...